{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:57:10Z","timestamp":1792421830885,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.clinthera.2025.03.009","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:37:25Z","timestamp":1744479445000},"page":"522-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Drug-Related Gastric Perforation Secondary to Prolonged Febuxostat Administration: A Case Report"],"prefix":"10.1016","volume":"47","author":[{"given":"Xiaoxu","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2364-8920","authenticated-orcid":false,"given":"Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clinthera.2025.03.009_bib0001","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMcp1001124","article-title":"Clinical practice. Gout","volume":"364","author":"Neogi","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.clinthera.2025.03.009_bib0002","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology Guidelines for Management of Gout Part I: systematic non-pharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.clinthera.2025.03.009_bib0003","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1592\/phco.30.6.594","article-title":"Urate-lowering therapy for gout: focus on febuxostat","volume":"30","author":"Love","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2025.03.009_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2020.573901","article-title":"An overview of gastroduodenal perforation","volume":"7","author":"Weledji","year":"2020","journal-title":"Front Surg"},{"issue":"1","key":"10.1016\/j.clinthera.2025.03.009_bib0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bj.2015.06.002","article-title":"Helicobacter pylori infection: an overview of bacterial virulence factors and pathogenesis","volume":"39","author":"Kao","year":"2016","journal-title":"Biomed J"},{"issue":"1","key":"10.1016\/j.clinthera.2025.03.009_bib0006","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12929-018-0466-9","article-title":"The impacts of H. pylori virulence factors on the development of gastroduodenal diseases","volume":"25","author":"Chang","year":"2018","journal-title":"J Biomed Sci"},{"issue":"9","key":"10.1016\/j.clinthera.2025.03.009_bib0007","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"issue":"13","key":"10.1016\/j.clinthera.2025.03.009_bib0008","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.3390\/diagnostics13132220","article-title":"Drug-associated gastropathy: diagnostic criteria","volume":"13","author":"Bordin","year":"2023","journal-title":"Diagnostics"},{"issue":"2","key":"10.1016\/j.clinthera.2025.03.009_bib0009","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"suppl_2","key":"10.1016\/j.clinthera.2025.03.009_bib0010","first-page":"ii15","article-title":"Febuxostat: a new treatment for hyperuricaemia in gout","volume":"48","author":"Edwards","year":"2009","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.clinthera.2025.03.009_bib0011","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.rdc.2012.08.008","article-title":"Safety of urate-lowering therapies: managing the risks to gain the benefits","volume":"38","author":"Keenan","year":"2012","journal-title":"Rheumatic Disease Clinics of North America"},{"issue":"2","key":"10.1016\/j.clinthera.2025.03.009_bib0012","doi-asserted-by":"crossref","DOI":"10.4081\/itjm.2024.1724","article-title":"A rare case of thrombocytopenia secondary to taking febuxostat","volume":"18","author":"Di Zio","year":"2024","journal-title":"Italian Journal of Medicine"},{"issue":"5","key":"10.1016\/j.clinthera.2025.03.009_bib0013","doi-asserted-by":"crossref","first-page":"744","DOI":"10.2215\/CJN.08280816","article-title":"Risk of febuxostat-associated myopathy in patients with CKD","volume":"12","author":"Liu","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.clinthera.2025.03.009_bib0014","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/hep.28403","article-title":"Drug-induced liver injury network (DILIN)","volume":"63","author":"Bohm","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2025.03.009_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106818","article-title":"A new avenue for enhanced treatment of hyperuricemia and oxidative stress: design, synthesis and biological evaluation of some novel mutual prodrugs involving febuxostat conjugated with different antioxidants","volume":"140","author":"Rashad","year":"2023","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/j.clinthera.2025.03.009_bib0016","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/164_2020_383","article-title":"Xanthine oxidoreductase inhibitors","volume":"264","author":"Vickneson","year":"2021","journal-title":"Handb Exp Pharmacol"},{"issue":"22","key":"10.1016\/j.clinthera.2025.03.009_bib0017","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.3390\/ijms20225635","article-title":"Anti-inflammatory and Anti-hyperuricemic functions of two synthetic hybrid drugs with dual biological active sites","volume":"20","author":"Almeer","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.clinthera.2025.03.009_bib0018","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/BOR.0000000000000861","article-title":"Update on gout management: what is old and what is new","volume":"34","author":"Afinogenova","year":"2022","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.clinthera.2025.03.009_bib0019","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/ph11020051","article-title":"Side effects and interactions of the xanthine oxidase inhibitor febuxostat","volume":"11","author":"Jordan","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.clinthera.2025.03.009_bib0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40262-016-0466-4","article-title":"Clinical pharmacokinetics and pharmacodynamics of febuxostat","volume":"56","author":"Kamel","year":"2017","journal-title":"Clinical pharmacokinetics"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825000852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825000852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T07:54:30Z","timestamp":1754553270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291825000852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0149291825000852"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.03.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-Related Gastric Perforation Secondary to Prolonged Febuxostat Administration: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}